MEDBRIGHT AI INVTS INC - MBAIF STOCK NEWS

MedBright AI has announced a strategic acquisition by Numinus Wellness, with plans to rebrand as Numinus Intelligence. This merger aims to integrate MedBright's AI capabilities with Numinus's expertise in mental health treatments, including drug-assisted therapies. The transaction is valued at $5M in cash and liquid securities, with MedBright shareholders receiving 1.86 Numinus shares per MedBright share, equating to roughly 39% ownership in the new entity. The deal is expected to enhance clinical operations and increase revenue for Numinus's mental health clinics in the US. The merger is contingent upon regulatory approvals and shareholder votes.

MedBright AI announced the launch of two new demonstration videos for the MedMatrix AI platform, showcasing the capabilities of the MedMatrix AI Reporter and Forecaster. These videos offer insights into clinic operations, market competition, revenue enhancement opportunities, claim efficiency, and resource efficiency. Users can simulate clinic scenarios and review detailed forecasts to make informed decisions about clinic management. The product demonstrations aim to showcase the power of the MedMatrix platform in providing valuable insights to healthcare providers.

MedBright AI Investments Inc. announces a multi-year deal with Dermatology Institute & Skin Care Center for the use of the MedMatrix AI Platform in their Santa Monica clinic. The contract includes all 5 product modules and aims to optimize clinical operations and enhance revenue opportunities.

MedBright AI Investments Inc. announces Rejuvenation medical group's adoption of MedMatrix AI Reporter for clinic operations reporting. Rejuvenation uses the tool across 8 clinics in Canada, aiming to enhance resource utilization and clinic growth.

MedBright AI Investments Inc. announces Dermatology Institute & Skin Care Center's use of MedMatrix AI Market Expander to evaluate new clinic locations in Southern California. The tool predicts optimal locations, saving time and increasing revenue potential.

MedBright AI Investments Inc. announced the go-to-market pricing for its AI product suite through MedMatrix, targeting the global outpatient clinic market. The suite aims to enhance clinic operations, revenue management, and market expansion. The pricing model offers a free trial and a revenue-sharing component, with a focus on the US market. MedBright's CEO highlights the company's strong value proposition and operating leverage.

MedBright AI Investments Inc. announced the completion of beta testing for MedMatrix, a product focusing on AI-driven optimization of healthcare facilities. The product suite includes five key features to enhance revenue and efficiency in outpatient clinics.

MedBright AI Investments Inc. announces the utilization of Limmi Disease Insights Platform in hospitals, focusing on kidney stone disease recurrence. UC San Diego Health is the first site to use Limmi's platform, aiming to minimize recurrence rates through AI-driven data analysis.

MedBright AI Investments Inc. announces the expansion of MedMatrix by Rejuvenation, a prominent dermatology group, to include marketing for cosmetic treatments and clinical trial recruitment and data analysis. Rejuvenation's extensive network includes 8 clinics spread across 3 provinces in Canada, with a highly skilled team. The expansion aims to further improve their leadership in cosmetic marketing and clinical trials, offering personalized recommendations to cosmetic patients and improving patient access to new treatments.